Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide to enhance Hepatitis B vaccine response in plasma cell dyscrasias
NCT02041325Phase 2Completed
- Sponsor
- Boston VA Research Institute
- Start
- Apr 2005
- Primary completion
- Jan 2011
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lenalidomide in hepatitis B (HBV), sponsored by Boston VA Research Institute. Started Apr 2005; status: completed.
02
Drugs
lenalidomide
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02041325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02041325.